Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Global Blood Ther (GBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,978,870
  • Shares Outstanding, K 56,322
  • Annual Sales, $ 0 K
  • Annual Income, $ -174,190 K
  • 60-Month Beta 2.13
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.93
  • Number of Estimates 10
  • High Estimate -0.74
  • Low Estimate -1.02
  • Prior Year -0.87
  • Growth Rate Est. (year over year) -6.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.09 +8.90%
on 03/06/19
54.88 -4.57%
on 02/26/19
+1.66 (+3.27%)
since 02/19/19
3-Month
34.92 +49.97%
on 12/24/18
54.88 -4.57%
on 02/26/19
+13.69 (+35.39%)
since 12/19/18
52-Week
30.15 +73.70%
on 11/30/18
54.88 -4.57%
on 02/26/19
-1.78 (-3.29%)
since 03/19/18

Most Recent Stories

More News
GBT Announces New Employment Inducement Grants

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on March 1, 2019, the compensation committee of GBT's board of directors granted 10 new employees options to purchase an aggregate...

GBT : 51.81 (-2.04%)
Detailed Research: Economic Perspectives on Intelsat S.A, Sprint, Restaurant Brands International, Tower Semiconductor, TE Connectivity, and Global Blood Therapeutics -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Intelsat S.A. (NYSE:I), Sprint Corporation...

TSEM : 16.87 (+1.32%)
QSR : 63.67 (+0.44%)
S : 6.38 (-1.39%)
GBT : 51.81 (-2.04%)
I : 16.60 (+3.62%)
TEL : 83.71 (+0.44%)
GBT Announces Participation at the Cowen and Company 39th Annual Health Care Conference

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the Cowen and Company 39 Annual Health Care Conference in Boston on Monday, March 11, 2019, at 4:50 p.m. Eastern...

GBT : 51.81 (-2.04%)
GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2018 Financial Results

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today reported recent business progress and financial results for the fourth quarter and year ended December 31, 2018.

GBT : 51.81 (-2.04%)
GBT Announces Participation at the 8th Annual SVB Leerink Global Healthcare Conference

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 8th Annual SVB Leerink Global Healthcare Conference in New York on Thursday, February 28, 2019, at 1 p.m....

GBT : 51.81 (-2.04%)
GBT Launches ACCEL Grants Program to Improve Access to Care for People with Sickle Cell Disease

--The Access to Excellent Care for Sickle Cell Patients Pilot Program (ACCEL) Supports Novel Projects Aimed at Improving Access to High-Quality Healthcare for People with Sickle Cell Disease--

GBT : 51.81 (-2.04%)
GBT Announces New Employment Inducement Grants

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on February 1, 2019, the compensation committee of GBT's board of directors granted 12 new employees options to purchase an aggregate...

GBT : 51.81 (-2.04%)
GBT Announces Publication of Data from Phase 1/2 Study of Voxelotor in Patients with Sickle Cell Disease

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that data from its Phase 1/2 study of voxelotor in patients with sickle cell disease (SCD) were published online in Blood, a peer-reviewed...

GBT : 51.81 (-2.04%)
Interesting GBT Put And Call Options For February 15th

Investors in Global Blood Therapeutics Inc saw new options become available this week, for the February 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GBT...

GBT : 51.81 (-2.04%)
GBT Announces New Employment Inducement Grants

Global Blood Therapeutics, Inc. (GBT or the Company) (NASDAQ: GBT) today announced that, on January 1, 2019, the compensation committee of the Company's board of directors granted three new employees options...

GBT : 51.81 (-2.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade GBT with:

Business Summary

Global Blood Therapeutics, Inc. is a biopharmaceutical company which is engaged in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. Its product candidate consists of GBT440 is an oral, once-daily prophylactic therapy for sickle cell disease which...

See More

Key Turning Points

2nd Resistance Point 55.02
1st Resistance Point 53.95
Last Price 51.81
1st Support Level 51.96
2nd Support Level 51.04

See More

52-Week High 54.88
Last Price 51.81
Fibonacci 61.8% 45.43
Fibonacci 50% 42.51
Fibonacci 38.2% 39.60
52-Week Low 30.15

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar